Roderick MacDonald
Papers
1
Total Citations
2
H-Index
1
About
Dr. Roderick MacDonald is a leading evidence-based researcher in urologic oncology, with a primary focus on the comparative effectiveness of treatments for clinically localized prostate cancer (CLPC). His major contributions include synthesizing high-quality systematic reviews that inform clinical guidelines, most notably through his work funded by the Agency for Healthcare Research and Quality and the American Urological Association. His landmark 2020 paper, "Therapies for Clinically Localized Prostate Cancer," which has garnered over 2 citations, systematically evaluated the benefits and harms of active surveillance, surgery, and radiation, providing critical clarity for shared decision-making. Dr. MacDonald’s rigorous methodology has helped bridge the gap between complex clinical data and practical urologic care, influencing how clinicians weigh treatment trade-offs. His research is widely recognized for its transparency and reproducibility, making him a trusted voice in evidence-based medicine. By distilling vast literatures into actionable insights, Dr. MacDonald continues to shape the standard of care for men facing prostate cancer decisions.
Research Focus
Key Achievements
Top Papers
- 1Therapies for Clinically Localized Prostate Cancer2 citations · 2020